Title: Clinical efficacy of budesonide combined with mucosolvan via inhalation therapy on children bronchiolitis
Abstract: Objective
To observe the clinical efficacy of budesonide combined with mucosolvan via inhalation therapy on children bronchiolitis.
Methods
A total of 106 children with bronchiolitis were divided into treatment group and control group, with 53 patients in each group. All patients underwent conventional comprehensive treatment, and on this basis treatment group received extra treatment with Mucosolvan combined with budesonide inhalation therapy based on the comprehensive therapy. The signs and symptoms ease or disappear time, length of stay in hospital and the treatment efficiency of two groups were compared.
Results
The signs and symptoms ease or disappear time in the treatment group were significantly shorter than those in the control group (P<0.05); the average length of stay in hospital of treatment group was shorter than control group (P<0.05). The treatment efficiency of treatment group was 84.9% (45/53), while that in the control group was 67.9% (36/53), the difference was significant (P<0.05).
Conclusions
Budesonide combined with Mucosolvan via inhalation therapy in treatment of children bronchiolitis can more quickly relieve symptoms and shorten the course of disease and improve treatment efficiency, its clinical effect is significant, and it should be popularized.
Key words:
Bronchiolitis; Budesonide; Mucosolvan
Publication Year: 2016
Publication Date: 2016-12-10
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot